https://peptidepolicywatch.com/2026/11/11/peptide-rush-enhanced-hims-datameds-who-announced-what/Peptide Policy Watchen2026-11-11The peptide rush is on. Is a new category forming? https://peptidepolicywatch.com/2026/11/11/b12-l-carnitine-peptides-plus-research-fda-status/Peptide Policy Watchen2026-11-11B12 and L-carnitine are on the Peptides+ list. They also have the longest FDA track record of the bunch https://peptidepolicywatch.com/2026/11/10/sermorelin-glutathione-nad-research-and-fda-status-compared/Peptide Policy Watchen2026-11-10Sermorelin, glutathione and NAD are about to hit the mainstream. What does the research say about each? https://peptidepolicywatch.com/2026/11/10/peg-mgf-mechano-growth-factor-research-fda-status/Peptide Policy Watchen2026-11-10PEG-MGF, the peptide named after your workout: what the muscle research found, and why FDA says it has no human data https://peptidepolicywatch.com/2026/11/10/hims-peptides-plus-launch-hhs-draft-policy/Peptide Policy Watchen2026-11-10Hims is bringing peptides to millions later this month. BPC-157 is next in line. https://peptidepolicywatch.com/2026/11/10/glp-1-naion-eye-warning-fda-label-changes/Peptide Policy Watchen2026-11-10GLP-1s just got a new label warning. It's about your eyes, not your waistline. https://peptidepolicywatch.com/2026/11/10/foundayo-orforglipron-sleep-apnea-attain-osa-results/Peptide Policy Watchen2026-11-10Lilly's GLP-1 pill eased sleep apnea in two trials. The 44% drop isn't the only number. https://peptidepolicywatch.com/2026/11/10/datameds-corexa-first-sale-hhs-six-peptides/Peptide Policy Watchen2026-11-10While Hims waits on BPC-157, a small pharmacy company says it has already sold one of HHS's six peptides